ARTICLE | Company News
Amgen, Maxygen hematology news
June 16, 2008 7:00 AM UTC
In an SEC filing, Maxygen said that after it files for regulatory approval of MAXY-G34, the company could potentially be sued by Amgen for infringement of Amgen’s newly issued U.S. Patent No. 7,381,8...